Evaluation of different techniques for identification of human papillomavirus types of low prevalence

Journal of Clinical Microbiology

Volumn 46, Issue 5, 2008, Pages 1606-1613

  Sabol, Ivan ^a   Salakova, Martina ^b   Smahelova, Jana ^b   Pawlita, Michal ^c   Schmitt, Markus ^c   Gašperov, Nina Milutin ^a   Grce, Magdalena ^a   Tachezy, Ruth ^b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOASSAY; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 40; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 54; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 73; INTERMETHOD COMPARISON; PREVALENCE; PRIORITY JOURNAL; RELIABILITY; UTERINE CERVIX; VIRUS IDENTIFICATION; VIRUS INFECTION; WART VIRUS;

FEMALE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRIDAE;

EID: 43249092199     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02328-07     Document Type: Article

References (36)

1. Bachtiary, B., A. Obermair, B. Dreier, P. Birner, G. Breitenecker, T. H. Knocke, E. Selzer, and R. Pötter. 2002. Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer. Int. J. Cancer 102:237-243.
2. Becker, T. M., C. M. Wheeler, N. S. McGough, C. A. Parmenter, S. W. Jordan, C. A. Stidley, R. S McPherson, and M. H. Dorin. 1994. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA 271:1181-1188.
3. Bosch, F. X., A. Lorincz, N. Munoz, C. J. Meijer, and K. V. Shah. 2002. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55:244-265.
4. Brink, A. A., P. J. Snijders, and C. J. Meijer. 2007. HPV detection methods. Dis. Markers 23:273-281.
5. Brummer, O., B. Hollwitz, G. Bohmer, H. Kuhnle, and K. U. Petry. 2006. Human papillomavirus-type persistence patterns predict the clinical outcome of cervical intraepithelial neoplasia. Gynecol. Oncol. 102:517-522.
6. Castle, P. E., P. E. Gravitt, D. Solomon, C. M. Wheeler, and M. Schiffman. 2008. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J. Clin. Microbiol. 46:109-117.
7. Coutlee, F., P. Gravitt, J. Kornegay, C. Hankins, H. Richardson, N. Lapointe, H. Voyer, and E. Franco. 2002. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J. Clin. Microbiol. 40:902-907.
8. de Roda Husman, A. M., J. M. Walboomers, A. J. van den Brule, C. J. Meijer, and P. J. Snijders. 1995. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76:1057-1062.
9. de Villiers, E. M., C. Fauquet, T. R. Broker, H. U. Bernard, and H. zur Hausen. 2004. Classification of papillomaviruses. Virology 324:17-27.
10. Doorbar, J. 2006. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. 110:525-541.
11. Fife, K. H., H. M. Cramer, J. M. Schroeder, and D. R. Brown. 2001. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J. Med. Virol. 64:550-559.
12. Gillio-Tos, A., L. De Marco, V. Ghisetti, P. J. Snijders, N. Segnan, G. Ronco, and F. Merletti. 2006. Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits. J. Clin. Virol. 36:126-132.
13. Gillison, M. L., and D. R. Lowy. 2004. A causal role for human papillomavirus in head and neck cancer. Lancet 363:1488-1489.
14. Gravitt, P. E., C. L. Peyton, T. Q. Alessi, C. M. Wheeler, F. Coutlee, A. Hildesheim, M. H. Schiffman, D. R. Scott, and R. J. Apple. 2000. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38:357-361.
15. Grce, M., K. Husnjak, L. Magdié, M. Ilijas, M. Zlački, D. Lepusić, J. Lukać, B. Hodek, V. Grizelj, A. Kurjak, Z. Kusić, and K. Pavelić. 1997. Detection and typing of human papillomaviruses by polymerase chain reaction in cervical scrapes of Croatian women with abnormal cytology. Eur. J. Epidemiol. 13:645-651.
16. Grce, M., K. Husnjak, J. Bozikov, L. Magdić, M. Zlački, J. Lukać, I. Fistonić, N. Sikanić-Dugić, and K. Pavelić. 2001. Evaluation of genital human papillomavirus infections by polymerase chainreaction among Croatian women. Anticancer Res. 21:579-584.
17. Herrero, R., A. Hildesheim, C. Bratti, M. E. Sherman, M. Hutchinson, J. Morales, I. Balmaceda, M. D. Greenberg, M. Alfaro, R. D. Burk, S. Wacholder, M. Plummer, and M. Schiffman. 2000. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J. Natl. Cancer Inst. 92:464-474.
18. Ho, G. Y., Y. Y. Studentsov, R. Bierman, and R. D. Burk. 2004. Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol. Biomarkers Prev. 13:110-116.
19. Kleter, B., L. J. van Doorn, J. ter Schegget, L. Schrauwen, K. van Krimpen, M. Burger, B. ter Harmsel, and W. Quint. 1998. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am. J. Pathol. 153:1731-1739.
20. Kleter, B., L. J. van Doorn, L. Schrauwen, A. Molijn, S. Sastrowijoto, J. ter Schegget, J. Lindeman, B. ter Harmsel, M. Burger, and W. Quint. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 37:2508-2517.
21. Manos, M. M., T. Ting, D. K. Wright, A. J. Levwis, T. R. Brer, and D. K. Wolinsky. 1989. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209-214.
22. Morrison, E. A., G. Y. Ho, S. H. Vermund, G. L. Goldberg, A. S. Kadish, E. F. Kelley, and R. D. Burk. 1991. Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int. J. Cancer 49:6-13.
23. Muñoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, C. J. Meijer, and International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
24. Muñoz, N., X. Castellsagué, A. B. de González, and L. Gissmann. 2006. HPV in the etiology of human cancer. Vaccine 24:S1-S10.
25. Qu, W., G. Jiang, Y. Cruz, C. J. Chang, G. Y. Ho, R. S. Klein, and R. D. Burk. 1997. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J. Clin. Microbiol. 35:1304-1310.
26. Remmerbach, T. W., U. G. Brinckmann, A. Hemprich, M. Chekol, K. Kuhndel, and U. G. Liebert. 2004. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J. Clin. Virol. 30:302-308.
27. Safaeian, M., R. Herrero, A. Hildesheim, W. Quint, E. Freer, L. J. Van Doorn, C. Porras, S. Silva, P. González, M. C. Bratti, A. C. Rodriguez, P. Castle, and Costa Rican Vaccine Trial Group. 2007. Comparison of the SPF10-LiPA system to the Hybrid Capture 2 assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica. J. Clin. Microbiol. 45:1447-1454.
28. Sasagawa, T., W. Basha, H. Yamazaki, and M. Inoue. 2001. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol. Biomarkers Prev. 10:45-52.
29. Schmitt, M., B. Dondog, T. Waterboer, and M. Pawlita. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J. Clin. Microbiol, doi: 10.1128/JCM.002227-07.
30. Solomon, D., and R. Nayar. 2004. The Bethesda system for reporting cervical cytology: definitions, criteria, and explanatory notes, 2nd ed. Springer-Verlag, New York, NY.
31. Tachezy, R., J. Smahelova, M. Salakova, L. Rob, P. Skapa, and E. Hamsikova. 2007. HPV types in Czech women with cervical precancerous lesions and invasive carcinoma, abstr. PS16-23, p. 271. Proc. 24th Int. Papillomavirus Conf., Beijing, China.
32. van den Brule, A. J., R. Pol, N. Fransen-Daalmeijer, L. M. Schouls, C. J. Meijer, and P. J. Snijders. 2002. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J. Clin. Microbiol. 40:779-787.
33. van der Graaf, Y., A. Molijn, H. Doornewaard, W. Quint, L. J. van Doorn, and J. van den Tweel. 2002. Human papillomavirus and the long-term risk of cervical neoplasia. Am. J. Epidemiol. 156:158-164.
34. van Doorn, L. J., W. Quint, B. Kleter, A. Molijn, B. Colau, M. T. Martin, Kravang-In, N. Torrez-Martinez, C. L. Peyton, and C. M. Wheeler. 2002. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J. Clin. Microbiol. 40:979-983.
35. van Doorn, L. J., A. Molijn, B. Kleter, W. Quint, and B. Colau. 2006. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J. Clin. Microbiol. 44:3292-3298.
36. van Hamont, D., M. A. van Ham, J. M. Bakkers, L. F. Massuger, and W. J. Melchers. 2006. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the Roche linear array HPV genotyping test. J. Clin. Microbiol. 44:3122-3129.